SCHEMBL13577682

SCHEMBL13577682

CC(C)C(C)c1nc2cnccc2c(=O)n1Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.47
KDM4E B2RXH2 3/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 2/20 0.47
RAD1 O60671 1/20 0.47
CFTR P13569 1/20 0.47
APEX1 P27695 1/20 0.47
CASP6 P55212 1/20 0.47
RAD51 Q06609 1/20 0.47
HKDC1 Q2TB90 1/20 0.47
GOPC Q9HD26 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP1A2 P05177 6/20 0.46
CYP2C9 P11712 5/20 0.46
CYP2C19 P33261 5/20 0.46
LMNA P02545 4/20 0.46
KDM4C Q9H3R0 2/20 0.46
RAB9A P51151 2/20 0.45
RECQL P46063 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5489353 0.88 ALDH1A1 (0.45) ALDH1A1KDM4EKMT2AMAPTRAD1
SCHEMBL4320409 0.88 ALDH1A1 (0.45) ALDH1A1KDM4EKMT2AMAPTRAD1
SCHEMBL16645078 0.81 KIF11 (0.56) ALDH1A1KMT2ATDP1CYP2C19LMNA
SCHEMBL4314434 0.81 PDE4A (0.52) ALDH1A1KDM4EKMT2AMAPTRAD1
SCHEMBL5118303 0.80 ALDH1A1 (0.43) ALDH1A1KDM4EKMT2AMAPTRAD1
SCHEMBL5489358 0.77 PDE4A (0.48) ALDH1A1KDM4EKMT2AMAPTRAD1
SCHEMBL6518180 0.77 PDE4A (0.66) ALDH1A1KDM4EKMT2AMAPTRAD1
SCHEMBL6026954 0.75 ALDH1A1 (0.56) ALDH1A1KDM4EKMT2AMAPTL3MBTL1
SCHEMBL6096918 0.75 ALDH1A1 (0.58) ALDH1A1KDM4EKMT2AMAPTL3MBTL1
SCHEMBL5111632 0.74 KIF11 (0.57) CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632839-B2 Mitotic kinesin inhibitors MERCK & CO. INC. (US) 2009-12-15 US disclosed
US-20080139586-A1 Mitotic Kinesin Inhibitors MERCK SHARP & DOHME CORP. 2008-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139586-A1 Mitotic Kinesin Inhibitors KIF5B, KIF2C, KIFC1 ALDH1A1 2486/4885KDM4E 473/4885KMT2A 454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.